Activation of BAD by Therapeutic Inhibition of Epidermal Growth Factor Receptor and Transactivation by Insulin-like Growth Factor Receptor-Reference-Cited by-同舟云学术

Activation of BAD by Therapeutic Inhibition of Epidermal Growth Factor Receptor and Transactivation by Insulin-like Growth Factor Receptor

Published:2002-08 Issue:31 Volume:277 Page:27643-27650
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Gilmore Andrew P.,Valentijn Anthony J.,Wang Pengbo,Ranger Ann M.,Bundred Nigel,O'Hare Michael J.,Wakeling Alan,Korsmeyer Stanley J.,Streuli Charles H.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference76 articles.

1. Proliferation, cell cycle and apoptosis in cancer

2. NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer

3. Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation.

4. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the BAD Protein Interactomes in 2D and 3D Cell Culture Using Proximity Labeling;Journal of Proteome Research;2024-07-03

2. Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer;npj Precision Oncology;2024-01-10

3. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine;Anti-Cancer Agents in Medicinal Chemistry;2023-04

4. Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer;Gynecologic Oncology;2023-03

5. Apoptotic priming is defined by the dynamic exchange of Bcl-2 proteins between mitochondria and cytosol;Cell Death & Differentiation;2022-05-18